Fat-Specific Sirt6 Ablation Sensitizes Mice to High-Fat Diet–Induced Obesity and Insulin Resistance by Inhibiting Lipolysis

Sirt6 is an NAD+-dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose tissue remains unknown. In this study, we showed that fat-specific Sirt6 knockout (FKO) sensitized mice to high-fat diet–induced obesity, which w...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 66; no. 5; pp. 1159 - 1171
Main Authors Kuang, Jiangying, Zhang, Yuwei, Liu, Qinhui, Shen, Jing, Pu, Shiyun, Cheng, Shihai, Chen, Lei, Li, Hong, Wu, Tong, Li, Rui, Li, Yanping, Zou, Min, Zhang, Zhiyong, Jiang, Wei, Xu, Guoheng, Qu, Aijuan, Xie, Wen, He, Jinhan
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.05.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Sirt6 is an NAD+-dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose tissue remains unknown. In this study, we showed that fat-specific Sirt6 knockout (FKO) sensitized mice to high-fat diet–induced obesity, which was attributed to adipocyte hypertrophy rather than adipocyte hyperplasia. The adipocyte hypertrophy in FKO mice likely resulted from compromised lipolytic activity as an outcome of decreased expression of adipose triglyceride lipase (ATGL), a key lipolytic enzyme. The suppression of ATGL in FKO mice was accounted for by the increased phosphorylation and acetylation of FoxO1, which compromises the transcriptional activity of this positive regulator of ATGL. Fat-specific Sirt6 KO also increased inflammation in the adipose tissue, which may have contributed to insulin resistance in high-fat diet–fed FKO mice. We also observed that in obese patients, the expression of Sirt6 expression is reduced, which is associated with a reduction of ATGL expression. Our results suggest Sirt6 as an attractive therapeutic target for treating obesity and obesity-related metabolic disorders.
AbstractList Sirt6 is an NAD -dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose tissue remains unknown. In this study, we showed that fat-specific Sirt6 knockout (FKO) sensitized mice to high-fat diet-induced obesity, which was attributed to adipocyte hypertrophy rather than adipocyte hyperplasia. The adipocyte hypertrophy in FKO mice likely resulted from compromised lipolytic activity as an outcome of decreased expression of adipose triglyceride lipase (ATGL), a key lipolytic enzyme. The suppression of ATGL in FKO mice was accounted for by the increased phosphorylation and acetylation of FoxO1, which compromises the transcriptional activity of this positive regulator of ATGL. Fat-specific Sirt6 KO also increased inflammation in the adipose tissue, which may have contributed to insulin resistance in high-fat diet-fed FKO mice. We also observed that in obese patients, the expression of Sirt6 expression is reduced, which is associated with a reduction of ATGL expression. Our results suggest Sirt6 as an attractive therapeutic target for treating obesity and obesity-related metabolic disorders.
Sirt6 is an NAD+-dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose tissue remains unknown. In this study, we showed that fat-specific Sirt6 knockout (FKO) sensitized mice to high-fat diet-induced obesity, which was attributed to adipocyte hypertrophy rather than adipocyte hyperplasia. The adipocyte hypertrophy in FKO mice likely resulted from compromised lipolytic activity as an outcome of decreased expression of adipose triglyceride lipase (ATGL), a key lipolytic enzyme. The suppression of ATGL in FKO mice was accounted for by the increased phosphorylation and acetylation of FoxO1, which compromises the transcriptional activity of this positive regulator of ATGL. Fat-specific Sirt6 KO also increased inflammation in the adipose tissue, which may have contributed to insulin resistance in high-fat diet-fed FKO mice. We also observed that in obese patients, the expression of Sirt6 expression is reduced, which is associated with a reduction of ATGL expression. Our results suggest Sirt6 as an attractive therapeutic target for treating obesity and obesity-related metabolic disorders.
Author Xu, Guoheng
Zhang, Yuwei
Cheng, Shihai
Jiang, Wei
Chen, Lei
Li, Yanping
Liu, Qinhui
Kuang, Jiangying
Zhang, Zhiyong
Li, Hong
Xie, Wen
He, Jinhan
Pu, Shiyun
Shen, Jing
Li, Rui
Wu, Tong
Qu, Aijuan
Zou, Min
Author_xml – sequence: 1
  givenname: Jiangying
  surname: Kuang
  fullname: Kuang, Jiangying
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 2
  givenname: Yuwei
  surname: Zhang
  fullname: Zhang, Yuwei
  organization: Division of Endocrinology and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 3
  givenname: Qinhui
  surname: Liu
  fullname: Liu, Qinhui
  organization: Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 4
  givenname: Jing
  surname: Shen
  fullname: Shen, Jing
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 5
  givenname: Shiyun
  surname: Pu
  fullname: Pu, Shiyun
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 6
  givenname: Shihai
  surname: Cheng
  fullname: Cheng, Shihai
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 7
  givenname: Lei
  surname: Chen
  fullname: Chen, Lei
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 8
  givenname: Hong
  surname: Li
  fullname: Li, Hong
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 9
  givenname: Tong
  surname: Wu
  fullname: Wu, Tong
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 10
  givenname: Rui
  surname: Li
  fullname: Li, Rui
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 11
  givenname: Yanping
  surname: Li
  fullname: Li, Yanping
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 12
  givenname: Min
  surname: Zou
  fullname: Zou, Min
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 13
  givenname: Zhiyong
  surname: Zhang
  fullname: Zhang, Zhiyong
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 14
  givenname: Wei
  surname: Jiang
  fullname: Jiang, Wei
  organization: Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
– sequence: 15
  givenname: Guoheng
  surname: Xu
  fullname: Xu, Guoheng
  organization: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China
– sequence: 16
  givenname: Aijuan
  surname: Qu
  fullname: Qu, Aijuan
  organization: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China
– sequence: 17
  givenname: Wen
  surname: Xie
  fullname: Xie, Wen
  organization: Center of Pharmacogenetics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA
– sequence: 18
  givenname: Jinhan
  surname: He
  fullname: He, Jinhan
  organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28250020$$D View this record in MEDLINE/PubMed
BookMark eNptkctKAzEUhoMoWqsLX0ACbnQxmkunmSzFa6EiWAV3Qy5nNDLN1ElmUUHwHXxDn8RUqwuREzjk5Pt_wvk30apvPCC0Q8kh41wcWU2HGWUsX0E9KrnMOBP3q6hHCGUZFVJsoM0Qngghw1TraIMVLCeEkR56PVcxm8zAuMoZPHFtHOJjXavoGo8n4IOL7gUCvnIGcGzwpXt4zJIGnzqIH2_vI287AxZfa0joHCtv8ciHrnYe36RRiMonpZ6n6aPTyc0_4LGbNfU8PW6htUrVAbaXvY_uzs9uTy6z8fXF6OR4nBkuZMxsYa20tLCyygeGKi0HgiiRC6gkE7QAS5XNdW6kMYxXlgtKKRSQbtpUA8P7aP_bd9Y2zx2EWE5dMFDXykPThZIWggtGeM4SuvcHfWq61qfflWm1jKYj80TtLqlOT8GWs9ZNVTsvfxabgINvwLRNCC1Uvwgl5SK0chFauQgtsUd_WOPiVwKxVa7-R_EJ89KaBQ
CitedBy_id crossref_primary_10_18632_oncotarget_18550
crossref_primary_10_1002_hep_30062
crossref_primary_10_1021_acsomega_3c04122
crossref_primary_10_1210_endocr_bqad147
crossref_primary_10_3389_fphys_2018_00135
crossref_primary_10_14336_AD_2022_0413
crossref_primary_10_3389_fendo_2018_00687
crossref_primary_10_3390_ijms20061462
crossref_primary_10_3389_fimmu_2024_1448535
crossref_primary_10_1038_s41467_021_23545_7
crossref_primary_10_3389_fphar_2019_00548
crossref_primary_10_1007_s00018_023_05093_z
crossref_primary_10_2337_dbi17_0025
crossref_primary_10_1002_jcp_29235
crossref_primary_10_1002_med_21753
crossref_primary_10_2337_db22_0362
crossref_primary_10_1530_JOE_17_0033
crossref_primary_10_1007_s00109_021_02082_2
crossref_primary_10_1007_s10565_022_09735_z
crossref_primary_10_3389_fendo_2018_00724
crossref_primary_10_1002_jcb_26046
crossref_primary_10_3389_fendo_2023_1244705
crossref_primary_10_1152_physrev_00030_2018
crossref_primary_10_1007_s11357_022_00713_1
crossref_primary_10_3389_jpps_2024_13080
crossref_primary_10_1016_j_bbadis_2020_165756
crossref_primary_10_1155_2018_6256052
crossref_primary_10_1016_j_ebiom_2018_11_005
crossref_primary_10_3390_biom12081079
crossref_primary_10_1186_s12933_019_0931_0
crossref_primary_10_18632_oncotarget_23259
crossref_primary_10_1016_j_apsb_2019_11_017
crossref_primary_10_1038_s41387_021_00168_x
crossref_primary_10_1002_jcsm_13734
crossref_primary_10_1016_j_phrs_2024_107493
crossref_primary_10_1002_iub_2707
crossref_primary_10_1038_s41467_019_10348_0
crossref_primary_10_1186_s12964_024_02025_7
crossref_primary_10_1007_s12272_017_0989_8
crossref_primary_10_3389_fonc_2022_861334
crossref_primary_10_3390_ijms20051153
crossref_primary_10_3390_ijms24119655
crossref_primary_10_3389_fphys_2018_00608
crossref_primary_10_1007_s00018_021_04061_9
crossref_primary_10_1002_jcp_28500
crossref_primary_10_1089_ars_2023_0295
crossref_primary_10_3389_fendo_2023_1286838
crossref_primary_10_2147_DMSO_S250699
crossref_primary_10_1074_jbc_RA118_005309
crossref_primary_10_3390_cells13010048
crossref_primary_10_1038_s42255_022_00644_3
crossref_primary_10_1152_ajpregu_00238_2021
crossref_primary_10_5937_hraIsh2101001M
crossref_primary_10_1038_s12276_021_00664_1
crossref_primary_10_1038_s41598_022_09174_0
crossref_primary_10_3389_fendo_2018_00748
crossref_primary_10_1186_s13148_024_01710_1
crossref_primary_10_1016_j_domaniend_2020_106513
crossref_primary_10_1042_CS20230433
crossref_primary_10_1007_s40618_020_01446_8
crossref_primary_10_1016_j_abb_2020_108260
crossref_primary_10_1016_j_lfs_2021_119803
crossref_primary_10_1186_s12979_024_00481_w
crossref_primary_10_1038_s12276_019_0256_9
crossref_primary_10_1074_jbc_RA120_014883
crossref_primary_10_1016_j_bbrc_2019_12_111
crossref_primary_10_4093_dmj_2022_0270
crossref_primary_10_1155_2020_7374086
crossref_primary_10_3389_jpps_2024_13062
crossref_primary_10_1007_s10787_019_00663_9
crossref_primary_10_1016_j_celrep_2019_11_067
crossref_primary_10_1016_j_mce_2020_110928
crossref_primary_10_1016_j_molmet_2020_100994
crossref_primary_10_1016_j_lfs_2019_116558
crossref_primary_10_1007_s00592_021_01759_x
crossref_primary_10_1080_10408363_2019_1699498
crossref_primary_10_1016_j_biopha_2023_114311
crossref_primary_10_1016_j_ymthe_2019_06_017
crossref_primary_10_1186_s10020_023_00676_9
crossref_primary_10_3390_nu16244424
crossref_primary_10_1096_fj_202002607
crossref_primary_10_1152_ajpendo_00057_2018
crossref_primary_10_3389_fphar_2020_598326
crossref_primary_10_1016_j_bcp_2022_115022
crossref_primary_10_1016_j_fsi_2020_01_029
crossref_primary_10_3390_cells12040663
crossref_primary_10_1007_s12012_024_09858_1
crossref_primary_10_1016_j_jphs_2020_12_008
crossref_primary_10_1002_cbf_3860
crossref_primary_10_1038_s41419_023_05582_w
crossref_primary_10_15252_embr_201846377
crossref_primary_10_1074_jbc_REV120_011438
crossref_primary_10_3389_fphys_2021_755060
Cites_doi 10.1016/j.cmet.2005.04.003
10.1016/j.febslet.2008.01.019
10.2337/db12-1039
10.1016/j.cmet.2010.06.009
10.1016/j.molcel.2012.09.030
10.1016/j.cmet.2011.09.012
10.1126/science.1123965
10.1038/ncomms6011
10.1016/j.cmet.2011.02.005
10.1016/j.jhep.2013.07.027
10.1007/s00125-006-0336-y
10.1016/j.cmet.2011.05.002
10.1042/CS20160465
10.1152/ajpendo.00122.2007
10.1016/j.cell.2009.12.041
10.1111/j.1474-9726.2009.00544.x
10.1126/science.1100747
10.1073/pnas.97.2.787
10.1074/jbc.M110.168039
10.1016/j.physbeh.2008.01.002
10.1152/ajpendo.00235.2007
10.1111/bph.13336
10.1016/S0022-2275(20)32429-9
10.1016/j.cell.2008.10.052
10.1038/nature12038
10.1146/annurev.nutr.27.061406.093734
10.1074/jbc.M113.515320
10.1074/jbc.M110.140228
10.1038/nm.3056
10.1016/j.cell.2005.11.044
10.1172/JCI26498
10.1074/jbc.C800241200
10.1016/j.cellsig.2005.08.009
10.1016/j.metabol.2015.02.005
10.1073/pnas.0502738102
10.2337/diabetes.54.11.3190
10.1053/j.gastro.2011.02.055
10.1016/j.cmet.2012.04.001
10.1038/nm.1904
10.1016/j.cmet.2011.12.018
10.1074/jbc.M508414200
10.2337/db08-1644
ContentType Journal Article
Copyright 2017 by the American Diabetes Association.
Copyright American Diabetes Association May 1, 2017
Copyright_xml – notice: 2017 by the American Diabetes Association.
– notice: Copyright American Diabetes Association May 1, 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
DOI 10.2337/db16-1225
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
EndPage 1171
ExternalDocumentID 28250020
10_2337_db16_1225
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.XZ
08P
0R~
18M
29F
2WC
354
4.4
53G
5GY
5RE
5RS
5VS
6PF
8R4
8R5
AAFWJ
AAQQT
AAWTL
AAYEP
AAYOK
AAYXX
ABOCM
ACGFO
ACGOD
ACPRK
ADBBV
AEGXH
AENEX
AERZD
AHMBA
AIAGR
AIZAD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BES
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EDB
EJD
EMOBN
EX3
F5P
FRP
GX1
H13
HZ~
IAO
IEA
IHR
INH
INR
IOF
IPO
K2M
KQ8
L7B
M5~
O5R
O5S
O9-
OHH
OK1
OVD
P2P
PCD
Q2X
RHI
RPM
SJN
SV3
TDI
TEORI
TR2
VVN
W8F
WH7
WOQ
WOW
X7M
YFH
YHG
YOC
ZY1
~KM
.GJ
1CY
3V.
7RV
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
8GL
AAKAS
AAYJJ
ABUWG
ADZCM
AFFNX
AFHIN
AFKRA
AI.
AZQEC
BBNVY
BCR
BCU
BEC
BENPR
BHPHI
BKEYQ
BKNYI
BLC
BPHCQ
BVXVI
C1A
CCPQU
CGR
CUY
CVF
DWQXO
ECM
EIF
FYUFA
GICCO
GNUQQ
GUQSH
HCIFZ
HMCUK
H~9
IAG
ITC
J5H
K-O
K9-
LK8
M0R
M1P
M2O
M2P
M2Q
M7P
MVM
N4W
NAPCQ
NPM
OB3
PEA
PKN
PQQKQ
PROAC
PSQYO
RHF
S0X
SJFOW
UKHRP
VH1
XOL
YQJ
ZGI
ZXP
K9.
7X8
ID FETCH-LOGICAL-c379t-d8dd9d18d9f54c1ab9470a757ef92718ed1ad5b5c9cc23fd37111e8ecc2bcf4c3
ISSN 0012-1797
IngestDate Fri Jul 11 04:59:27 EDT 2025
Fri Jul 25 19:24:58 EDT 2025
Wed Feb 19 02:42:50 EST 2025
Tue Jul 01 03:11:00 EDT 2025
Thu Apr 24 23:11:04 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License 2017 by the American Diabetes Association.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c379t-d8dd9d18d9f54c1ab9470a757ef92718ed1ad5b5c9cc23fd37111e8ecc2bcf4c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 28250020
PQID 1932132195
PQPubID 34443
PageCount 13
ParticipantIDs proquest_miscellaneous_1873720352
proquest_journals_1932132195
pubmed_primary_28250020
crossref_primary_10_2337_db16_1225
crossref_citationtrail_10_2337_db16_1225
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-05-01
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: 2017-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle Diabetes (New York, N.Y.)
PublicationTitleAlternate Diabetes
PublicationYear 2017
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Zechner (2022031303354640200_B5) 2012; 15
Zhong (2022031303354640200_B42) 2010; 140
Kanfi (2022031303354640200_B17) 2010; 9
Qiang (2022031303354640200_B30) 2010; 285
Festuccia (2022031303354640200_B38) 2006; 49
Langin (2022031303354640200_B3) 2005; 54
Chakrabarti (2022031303354640200_B9) 2009; 284
Pu (2022031303354640200_B26) 2016; 173
Carmen (2022031303354640200_B35) 2006; 18
Glass (2022031303354640200_B40) 2012; 15
Steinberg (2022031303354640200_B39) 2007; 293
Jaworski (2022031303354640200_B25) 2009; 15
Liew (2022031303354640200_B33) 2013; 19
Van Meter (2022031303354640200_B23) 2014; 5
Kanda (2022031303354640200_B43) 2006; 116
Moschen (2022031303354640200_B19) 2013; 59
Duncan (2022031303354640200_B1) 2007; 27
Ahmadian (2022031303354640200_B11) 2011; 13
Matsuzaki (2022031303354640200_B31) 2005; 102
Kawahara (2022031303354640200_B41) 2009; 136
Zimmermann (2022031303354640200_B6) 2004; 306
Jiang (2022031303354640200_B22) 2013; 496
Kanfi (2022031303354640200_B15) 2008; 582
Jocken (2022031303354640200_B36) 2008; 94
Kim (2022031303354640200_B16) 2010; 12
Kurat (2022031303354640200_B8) 2006; 281
Faust (2022031303354640200_B2) 1978; 235
Ahmadian (2022031303354640200_B12) 2009; 58
Kershaw (2022031303354640200_B13) 2007; 293
Xiao (2022031303354640200_B28) 2010; 285
Large (2022031303354640200_B34) 1999; 40
Banks (2022031303354640200_B37) 2011; 14
He (2022031303354640200_B21) 2013; 62
Mostoslavsky (2022031303354640200_B14) 2006; 124
He (2022031303354640200_B24) 2015; 64
Eguchi (2022031303354640200_B29) 2011; 13
Grönke (2022031303354640200_B7) 2005; 1
Kwok (2022031303354640200_B32) 2016; 130
Dominy (2022031303354640200_B18) 2012; 48
He (2022031303354640200_B27) 2011; 140
Haemmerle (2022031303354640200_B10) 2006; 312
Osuga (2022031303354640200_B4) 2000; 97
Nguyen (2022031303354640200_B20) 2014; 289
References_xml – volume: 1
  start-page: 323
  year: 2005
  ident: 2022031303354640200_B7
  article-title: Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2005.04.003
– volume: 582
  start-page: 543
  year: 2008
  ident: 2022031303354640200_B15
  article-title: Regulation of SIRT6 protein levels by nutrient availability
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2008.01.019
– volume: 62
  start-page: 1876
  year: 2013
  ident: 2022031303354640200_B21
  article-title: PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice
  publication-title: Diabetes
  doi: 10.2337/db12-1039
– volume: 12
  start-page: 224
  year: 2010
  ident: 2022031303354640200_B16
  article-title: Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2010.06.009
– volume: 48
  start-page: 900
  year: 2012
  ident: 2022031303354640200_B18
  article-title: The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2012.09.030
– volume: 235
  start-page: E279
  year: 1978
  ident: 2022031303354640200_B2
  article-title: Diet-induced adipocyte number increase in adult rats: a new model of obesity
  publication-title: Am J Physiol
– volume: 14
  start-page: 587
  year: 2011
  ident: 2022031303354640200_B37
  article-title: Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2011.09.012
– volume: 312
  start-page: 734
  year: 2006
  ident: 2022031303354640200_B10
  article-title: Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
  publication-title: Science
  doi: 10.1126/science.1123965
– volume: 5
  start-page: 5011
  year: 2014
  ident: 2022031303354640200_B23
  article-title: SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age
  publication-title: Nat Commun
  doi: 10.1038/ncomms6011
– volume: 13
  start-page: 249
  year: 2011
  ident: 2022031303354640200_B29
  article-title: Transcriptional control of adipose lipid handling by IRF4
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2011.02.005
– volume: 59
  start-page: 1315
  year: 2013
  ident: 2022031303354640200_B19
  article-title: Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2013.07.027
– volume: 49
  start-page: 2427
  year: 2006
  ident: 2022031303354640200_B38
  article-title: PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control
  publication-title: Diabetologia
  doi: 10.1007/s00125-006-0336-y
– volume: 13
  start-page: 739
  year: 2011
  ident: 2022031303354640200_B11
  article-title: Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2011.05.002
– volume: 130
  start-page: 2087
  year: 2016
  ident: 2022031303354640200_B32
  article-title: Adipose-specific inactivation of JNK alleviates atherosclerosis in apoE-deficient mice
  publication-title: Clin Sci (Lond)
  doi: 10.1042/CS20160465
– volume: 293
  start-page: E1736
  year: 2007
  ident: 2022031303354640200_B13
  article-title: PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00122.2007
– volume: 140
  start-page: 280
  year: 2010
  ident: 2022031303354640200_B42
  article-title: The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha
  publication-title: Cell
  doi: 10.1016/j.cell.2009.12.041
– volume: 9
  start-page: 162
  year: 2010
  ident: 2022031303354640200_B17
  article-title: SIRT6 protects against pathological damage caused by diet-induced obesity
  publication-title: Aging Cell
  doi: 10.1111/j.1474-9726.2009.00544.x
– volume: 306
  start-page: 1383
  year: 2004
  ident: 2022031303354640200_B6
  article-title: Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase
  publication-title: Science
  doi: 10.1126/science.1100747
– volume: 97
  start-page: 787
  year: 2000
  ident: 2022031303354640200_B4
  article-title: Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.97.2.787
– volume: 285
  start-page: 36776
  year: 2010
  ident: 2022031303354640200_B28
  article-title: SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.168039
– volume: 94
  start-page: 219
  year: 2008
  ident: 2022031303354640200_B36
  article-title: Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity
  publication-title: Physiol Behav
  doi: 10.1016/j.physbeh.2008.01.002
– volume: 293
  start-page: E958
  year: 2007
  ident: 2022031303354640200_B39
  article-title: Adipocyte triglyceride lipase expression in human obesity
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00235.2007
– volume: 173
  start-page: 66
  year: 2016
  ident: 2022031303354640200_B26
  article-title: Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.13336
– volume: 40
  start-page: 2059
  year: 1999
  ident: 2022031303354640200_B34
  article-title: Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects
  publication-title: J Lipid Res
  doi: 10.1016/S0022-2275(20)32429-9
– volume: 136
  start-page: 62
  year: 2009
  ident: 2022031303354640200_B41
  article-title: SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span
  publication-title: Cell
  doi: 10.1016/j.cell.2008.10.052
– volume: 496
  start-page: 110
  year: 2013
  ident: 2022031303354640200_B22
  article-title: SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine
  publication-title: Nature
  doi: 10.1038/nature12038
– volume: 27
  start-page: 79
  year: 2007
  ident: 2022031303354640200_B1
  article-title: Regulation of lipolysis in adipocytes
  publication-title: Annu Rev Nutr
  doi: 10.1146/annurev.nutr.27.061406.093734
– volume: 289
  start-page: 1688
  year: 2014
  ident: 2022031303354640200_B20
  article-title: Very low density lipoprotein receptor (VLDLR) expression is a determinant factor in adipose tissue inflammation and adipocyte-macrophage interaction
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M113.515320
– volume: 285
  start-page: 27396
  year: 2010
  ident: 2022031303354640200_B30
  article-title: Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.140228
– volume: 19
  start-page: 217
  year: 2013
  ident: 2022031303354640200_B33
  article-title: Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance
  publication-title: Nat Med
  doi: 10.1038/nm.3056
– volume: 124
  start-page: 315
  year: 2006
  ident: 2022031303354640200_B14
  article-title: Genomic instability and aging-like phenotype in the absence of mammalian SIRT6
  publication-title: Cell
  doi: 10.1016/j.cell.2005.11.044
– volume: 116
  start-page: 1494
  year: 2006
  ident: 2022031303354640200_B43
  article-title: MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
  publication-title: J Clin Invest
  doi: 10.1172/JCI26498
– volume: 284
  start-page: 13296
  year: 2009
  ident: 2022031303354640200_B9
  article-title: FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes
  publication-title: J Biol Chem
  doi: 10.1074/jbc.C800241200
– volume: 18
  start-page: 401
  year: 2006
  ident: 2022031303354640200_B35
  article-title: Signalling mechanisms regulating lipolysis
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2005.08.009
– volume: 64
  start-page: 826
  year: 2015
  ident: 2022031303354640200_B24
  article-title: Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2015.02.005
– volume: 102
  start-page: 11278
  year: 2005
  ident: 2022031303354640200_B31
  article-title: Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0502738102
– volume: 54
  start-page: 3190
  year: 2005
  ident: 2022031303354640200_B3
  article-title: Adipocyte lipases and defect of lipolysis in human obesity
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.11.3190
– volume: 140
  start-page: 2095
  year: 2011
  ident: 2022031303354640200_B27
  article-title: PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2011.02.055
– volume: 15
  start-page: 635
  year: 2012
  ident: 2022031303354640200_B40
  article-title: Inflammation and lipid signaling in the etiology of insulin resistance
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2012.04.001
– volume: 15
  start-page: 159
  year: 2009
  ident: 2022031303354640200_B25
  article-title: AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency
  publication-title: Nat Med
  doi: 10.1038/nm.1904
– volume: 15
  start-page: 279
  year: 2012
  ident: 2022031303354640200_B5
  article-title: Fat signals--lipases and lipolysis in lipid metabolism and signaling
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2011.12.018
– volume: 281
  start-page: 491
  year: 2006
  ident: 2022031303354640200_B8
  article-title: Obese yeast: triglyceride lipolysis is functionally conserved from mammals to yeast
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M508414200
– volume: 58
  start-page: 855
  year: 2009
  ident: 2022031303354640200_B12
  article-title: Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity
  publication-title: Diabetes
  doi: 10.2337/db08-1644
SSID ssj0006060
Score 2.541596
Snippet Sirt6 is an NAD+-dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose...
Sirt6 is an NAD -dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 1159
SubjectTerms Ablation
Acetylation
Adipocytes - metabolism
Adipocytes - pathology
Adipose tissue
Adipose Tissue - metabolism
Adipose Tissue, White - metabolism
Adipose Tissue, White - pathology
Adult
Animals
Blotting, Western
Cell Enlargement
Chromatin Immunoprecipitation
Diet
Diet, High-Fat
Energy
Energy metabolism
Flow Cytometry
Forkhead Box Protein O1 - metabolism
FOXO1 protein
Glucose Tolerance Test
High fat diet
Humans
Hyperplasia
Hypertrophy
Immunoprecipitation
Inflammation
Insulin
Insulin resistance
Insulin Resistance - genetics
Lipase
Lipase - genetics
Lipase - metabolism
Lipolysis
Lipolysis - genetics
Metabolic disorders
Metabolism
Mice
Mice, Knockout
Middle Aged
NAD
Obesity
Obesity - genetics
Oils & fats
Phosphorylation
Real-Time Polymerase Chain Reaction
Rodents
Sirtuins - genetics
Transcription
Title Fat-Specific Sirt6 Ablation Sensitizes Mice to High-Fat Diet–Induced Obesity and Insulin Resistance by Inhibiting Lipolysis
URI https://www.ncbi.nlm.nih.gov/pubmed/28250020
https://www.proquest.com/docview/1932132195
https://www.proquest.com/docview/1873720352
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB7WCuKLeHdtlVF8EEp0k0k2mceillqpoG1hfQpzSxuQbGkTSguC_8E_4e_yl3hO5rLpWqEKS1gmOZPdPV_Obc-FkBcTnWplALzTaWqiVE50xI0uoiKtBNgfZporrB3e-Tjd2k-3Z9lsNPo5yFrqWvlKnV9aV_I_XIU14CtWyf4DZ8OmsADvgb9wBA7D8Uo83hRt1A-Qr2q1vlsft9P1DWmT20AINJiOdW5OMDW-H5CBOR0R0ICcM63PcmA4vAOTANyIAJcgbDPUP8MSmo9AD2bq--awlnVr66KO5n0zk6Fx-3YQx12e8DOIOHzoXIx6G6B5cOZ15zB6_aU7NXXIFao7XPtUN4ddWNz1VSWe3EUuQBuGPEEvjeME26NahWusAOaMRyzJZ0MJbeeyOCRmA3EL5iwfqO44tuNcltVCwvrGAlrGOHPIFlpfbL29pBJDoiK4SEhcImmJpNfI9QQcEubjQk7ngxtoi53cN7I9rJD0dbjrRcvnL-5Mb9bs3Sa3nD9CNyy47pCRae6SGzsu4-Ie-TbEGO0xRj3G6AJjFDFG2zn1GKOIsV_ffzh0UYcuCuiiDl10gS4qz-gCXTSg6z7Z33y392YrciM7IsVy3ka60JrruNC8ylIVC8nTfCLyLDcVT8AMMjoWOpOZ4kolrNIsB11rCpAjiVRVqtgDstLMG_OIUAGmlWSwX8FT2KTimRC9CpIgVTgXY_LS_5ylcv3scazK1_IPpo3J83DpkW3ictlFa54npXvGT0p0b2J4cTj9LJwGCYx_q4nGzDu4puhHPYEnMyYPLS_DXbAyHD2yx1f5BKvk5uIxWSMr7XFnnoDJ28qnPdp-AxM7q9A
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fat-Specific+Sirt6+Ablation+Sensitizes+Mice+to+High-Fat+Diet%E2%80%93Induced+Obesity+and+Insulin+Resistance+by+Inhibiting+Lipolysis&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Kuang%2C+Jiangying&rft.au=Zhang%2C+Yuwei&rft.au=Liu%2C+Qinhui&rft.au=Shen%2C+Jing&rft.date=2017-05-01&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=66&rft.issue=5&rft.spage=1159&rft.epage=1171&rft_id=info:doi/10.2337%2Fdb16-1225&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_db16_1225
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon